Clinical Trial Update: NFKB1 and IKK Epsilon in Rheumatoid Arthritis

View source ↗

Summary

The clinical trial investigating NFKB1 and IKK epsilon in rheumatoid arthritis has completed; the provided snippet does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Asociación Científica Latina A.C. | Conditions: Rheumatoid Arthritis | Status: COMPLETED